You were told it was a heat rash. Then a fungal rash. Then that your bra did not fit, that you should wear cotton, keep the area dry, use powder. You did all of it. Meanwhile the lumps kept coming — under the breast, in the crease, sometimes on the side of the chest wall or between the breasts — and now some of them have left thick, dark, tethered scars, and one of them never really closes.
Inframammary HS is almost exclusively a women's disease, and it is dismissed for longer than almost any other site. The reason is simple: everything about it is easy to explain away as women's ordinary discomfort. Heat. Sweat. Underwire. Weight. Being a woman with breasts. So nobody looks past it, sometimes for a decade.
The inframammary fold is apocrine-dense, warm, closed, and in continuous skin-on-skin shear. It is a low-threshold site for follicular occlusion — the initiating event in HS.
Heat, sweat and friction are conditions that let it surface. They are not what causes it. HS is not a skin condition with systemic complications; it is a systemic condition expressing through the skin, driven by gut dysbiosis, immune dysregulation, hormonal signalling and insulin resistance. That hormonal driver is worth naming here, because breast and chest-fold disease very often flares premenstrually and very often sits in women with an androgen-driven picture — irregular cycles, PCOS, adult acne, unwanted hair growth.
A perfectly fitted bra in a cool room will make you more comfortable. It will not stop your immune system from doing this.
Sweat rash. Intertrigo. Fungal infection — with antifungals prescribed repeatedly that never quite work. Boils. Infected cysts. Blocked milk ducts, if you are breastfeeding or ever have been. "Friction." "You just need to lose weight." Lesions get drained; antibiotics settle them; they return.
Two things point to HS: recurrence in the same folds over years, and a second site — armpits, groin, buttocks. If you have lumps in the crease under your breast and lumps in your armpits, you almost certainly do not have two separate skin problems.
Phase L, Inflammatory Load Reduction (oral), lowers the inflammatory pressure driving each rupture, so lesions in the fold stop escalating. Phase I, Internal Correction (oral), addresses the gut and immune drivers underneath — and where hormonal and insulin-resistance drivers are dominant, as they frequently are in inframammary disease, that is where the correction is aimed. Phase F, Functional Clearance (oral), clears accumulated load, and is only ever started after L and I are stable; brought forward, it mobilises load faster than your system can clear it and the disease gets worse, not better. Phase E, External Tissue Repair, is a topical used at home in a fold that is wet, raw or scarring. Phase S, Remission Maintenance, is a tapered oral phase across six to twelve months.
There is no procedure and no clinic visit at any stage. You will not be asked to undress in front of anyone.
If your flares track your cycle, say so at the first consultation. It is one of the most useful pieces of information you can give, and it changes what is prioritised.
Weeks three to six is where most people improve, then feel it stall. This is the Partial Improvement Plateau. It looks like the treatment has stopped working. It has not — it is the point where surface change outpaces internal change, and it is the point at which most patients give up, just before the deeper shift.
Active nodules can settle, the fold can stop being permanently inflamed, and new lesion formation can slow and then stop. What cannot be undone is what has already been built: established sinus tunnels running along the fold, and the thickened, tethered, discoloured scarring that chronic inframammary disease leaves behind. Tunnels are structural. Reversal work can quieten and shrink them and stop new ones forming; it may not fully close a mature tract. Scarred skin does not become the skin you had before. Pigmentation may soften over a long period, but it may not clear.
EPOH-DSS Stage 1 early nodular, EPOH-DSS Stage 2 inflammatory, EPOH-DSS Stage 3 sinus, EPOH-DSS Stage 4 advanced tunneling — mapping onto the Hurley grades you have probably read about. Treatment response is tracked on a separate scale: Recovery Stage 1 internal shift, Recovery Stage 2 reduced frequency, Recovery Stage 3 reduced severity, Recovery Stage 4 stable remission.
Consultation is by video or WhatsApp, with a woman doctor if you would prefer one — ask. Formulations are couriered to you and used at home, so there is no examination and no clinic visit at any point. Send your history, your cycle pattern and photographs, and you will be told honestly what is achievable, including if the honest answer is partial.
Medical disclaimer. This page is general clinical information, not personalised medical advice. Individual response varies with disease duration, degree of involvement and remaining biological repair capacity — not every patient reaches the same outcome. No medication should be started, stopped or altered without consulting your treating physician.
A consultation assesses your driver profile and what root-cause correction can realistically achieve in your case. If we do not think we can help you, we will tell you.
Consultations by video or WhatsApp. Personalised formulations couriered to your door, in India and internationally. No clinic visit required at any stage. How treatment works →